Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
FRACTURE RISK ASSESSMENT Determining your risk of breaking a bone Rather than relying solely on the results of a bone mineral density (BMD) test to make treatment decisions for osteoporosis, […]
Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, and Dr. Emma Billington. Recommendations from Osteoporosis Canada Rapid Response Team. The Canadian Centre on Substance Use and […]
Aliya Khan, Heather Frame, Claudia Gagnon, Rowena Ridout , Lianne Tile, Wendy Ward, Sandra Kim Recently Duerksen and colleagues published on fracture risk assessment in celiac disease – a registry-based […]
Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]
Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]
CMC 2023 The Canadian Musculoskeletal Conference (CMC) hosted by Osteoporosis Canada is November 23 and 24, 2023. Led by national and international experts in osteoporosis, this dynamic conference will offer […]
